|
|
|
|
| Advertisement |
 |
|
|
| Top Story |
 |
|
Government Shutdown: Impact on FDA |
FDA restarted full operations on January 28 following Congressional agreement on a continuing resolution to fund government operations for three weeks. But the situation will get much worse if Congress and the White House fail to negotiate a longer-term budget for 2019 by February 15, writes Jill Wechsler.
… /Read more/ |
|
|
| Advertisement |
DCAT Week: Business Development—Networking—Education
DCAT Week is the premier global event for the business of pharmaceutical development and manufacturing (March 18–21 in New York City). Organized by the Drug, Chemical & Associated Technologies Association, its unique model brings together members for high-level strategic meetings with key decision makers, timely educational programs and important networking opportunities.
 Learn more
|
|
|
ADVERTISEMENT
|
|
| Advertisement |
 |
|
|
| Technology |
 |
|
Exploring AI in Pharmaceuticals |
Donna Conroy and Michael Conroy define AI in context of the pharma industry, outline its current utilization, and highlight considerations for companies contemplating an internal AI investment.
… /Read more/ |
|
|
|
| Value-Based Pricing |
 |
|
ICER: Going Global |
The Institute for Clinical Effectiveness Review (ICER) has set up a working group to bring together the expertise of NICE and other key HTAs to develop new methods to guide value-based pricing of potential cures. Leela Barham reports
… /Read More/ |
| |
|
|
|
|
 |
|
The Pharm Exec Podcast: Mindfulness in Clinical Trial R&D |
Raymond Sanchez, senior vice president of Global Clinical Development at Otsuka Pharmaceutical Development & Commercialization talks about his switch from academia to clinical development, the effect of seeing a drug he helped develop on the pharmacy shelf, and how he uses mindfulness to encourage and lead his team
… /Read More/ |
|
|
|
|
|
/ February 12–13: Speaker Programs 2019
/ |
|
Philadelphia, PA |
|
/ February 20–21: Oncology Market Access Strategy Summit
/ |
|
San Francisco, CA |
|
/ February 26–27: 12th Hub and SPP Model Optimization
/ |
|
Philadelphia, PA |
|
/ March 4–6: 20th Annual Patient Assistance and Access Programs – PAP 2019
/ |
|
Baltimore, MD |
|
/ March 12–13: Pharmaceutical Compliance Congress Asia
/ |
|
Shanghai, China |
|
/ March 12–13: e-Rx and EHR 2019
/ |
|
Philadelphia, PA |
|
/ March 12–14: 17th Annual eyeforpharma Barcelona
/ |
|
Barcelona, Spain |
|
/ March 18–21: DCAT Week '19
/ |
|
New York City, NY |
|
/ March 20–22: 15th Life Sciences Accounting and Reporting Congress
/ |
|
Philadelphia, PA |
|
/ March 20–March 21: Partnering with IDNs Biopharma Strategy Summit West
/ |
|
Scottsdale, AZ |
|
/ March 27–28: 12th Annual Expanded Access Programs
/ |
|
Philadelphia, PA |
|
/ June 12–13: Rare Disease Innovation and Partnering Summit
/ |
|
Boston, MA |
|
|
|
|
|
| Industry update |
| //
Dynavax Technologies Corporation (Berkeley, CA) named Heather Rowe as Vice President of Investor Relations and Corporate Communications.
//
Portola Pharmaceuticals (South San Francisco, CA) appointed Sheldon Koenig as Executive Vice President and Chief Commercial Officer.
//
MyoKardia (South San Francisco, CA) appointed William C. Fairey as Chief Commercial Officer and Executive Vice President.
//
Taiwan Liposome Company (Taipei, Taiwan and South San Francisco, CA) appointed George Spencer-Green, MD, MS, as its new Chief Medical Officer.
//
Anup Marda, MBA, was named Chief Financial Officer of Cabaletta Bio (Radnor, PA).
//
Flexion Therapeutics (Burlington, MA) appointed Christina Willwerth as Chief Strategy Officer.
//
Apollomics (Foster City, CA and Hangzhou, China) announced the appointments of Wilson W. Cheung, CPA as Executive Vice President and Chief Financial Officer, and Debra L. Thoma Vallner, PhD, MBA as Senior Vice President, Development Operations.
|
|
|
|
|
